Reckitt Mucinex Patent Gets Reprieve As Appeals Court Rules Against Perrigo
This article was originally published in The Tan Sheet
Executive Summary
An appeals court decision against Perrigo further delays the private labeler's plans to launch a Mucinex equivalent, leaving the Reckitt Benckiser decongestant still unchallenged by generic competition